Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Novel targeted therapies in breast cancer

Bora Lim • 14 Dec 2020
SABCS 2020
Breast Cancer Ipatasertib Neratinib Palbociclib
IPATunity130

Bora Lim, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, provides an outline of a talk at the San Antonio Breast Cancer Symposium (SABCS) 2020, where Dr Lim discussed novel targeted therapies in breast cancer, including those that act on the AKT-PI3K pathways, as evaluated in the IPATunity130 study (NCT03337724). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Bora Lim

1:32
Highlights at SABCS 2021 for basic science and early-phase clinical trials
Bora Lim • 9 Dec 2021
1:48
Single-cell genomics and proteogenomics in cancer
Bora Lim • 9 Dec 2021
1:40
Advances in the management of inflammatory breast cancer
Bora Lim • 9 Dec 2021
1:32
Treatment algorithm for TNBC
Bora Lim • 9 Dec 2021

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals